Recruiting
Phase 1

Observational Study

Sponsor:

Boulder Care

Code:

NCT07169409

Conditions

Opioid Use Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Telemedicine Buprenorphine Treatment

Study Details

Brief summary:

Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment as well as business profitability.

Conditions

Opioid Use Disorder

Study ID

NCT07169409

Start date

Jun 10, 2025

Status verified date

Sep, 2025

Completion date

Sep 15, 2027

Anticipated

Primary completion date

Aug, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • History of Opioid Use Disorder (OUD)
  • Starting OUD treatment with buprenorphine, or within 45 days of starting or restarting this medication
  • Speak and understand English

Exclusion Criteria:

  • History of allergic reaction to buprenorphine
  • Plans to move out of a Boulder Care-affiliated state site in the next 12 months (precluding continuation of care)
  • Untreated mental or medical health conditions that, in the opinion of the participant, would preclude study participation

Study Design

Enrollment

250 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Receiving Intervention

Interventions

Telemedicine Buprenorphine Treatment

With this NIDA-funded grant, the study team will identify app-based treatment workflows that are demonstrably effective in low-resource settings: namely, telehealth services that are accessible without high-speed internet and deliberately helping patients transition into OUD care from relevant health and community system settings. An intentional focus on rural areas and Black and Hispanic demographics will help enhance health equity, and support solutions for payors.

Primary outcome measure

  • Intervention Acceptability, Appropriateness, Feasibility [ Time Frame: 48 weeks ]

Central Contacts and Locations

Central contacts

Andrea Baron, MPH

408-483-2766andrea.baron@boulder.care

Laura Monico, PhD

855-605-8816laura.monico@boulder.care

Locations

Boulder Care

Recruiting

Portland, Oregon, United States, 97204

Contacts

Andrea Baron, MPH

4084832766andrea.baron@boulder.care

Laura Monico, PhD

855-605-8816laura.monico@boulder.care

Principal Investigator:

Stephanie Papes

More Information

Sponsor

Boulder Care

Last update posted

Sep 11, 2025

Last verified

Sep, 2025

Keywords

  • telehealth

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boulder Care on 2025-09-11.